Evaluating Future Biopharmaceutical Inspection Needs , Infrastructure
نویسندگان
چکیده
The biotechnology industry is undergoing a paradigm shift in the properties of the manufactured drug product. As therapeutic protein formulations change from agonist to antagonist methods of action, the concentration of proteins in each dose increased by orders of magnitude, and with it, the challenge of producing and inspecting the product. Current inspection technologies meet the requirements to properly inspect the existing drug product portfolio, but as new pipeline drugs enter commercial manufacturing, inspection will become a pressing issue from operational efficiency, compliance, and quality standpoints. It is known that the properties of some of these pipeline products render them "uninspectable" by currently installed Automatic Visual Inspection Machines (AVIMs) but the scale and scope of the challenge is not well defined currently. The process and approach outlined in this research focuses on distilling large datasets of future product forecasts together with product attributes and infrastructure capability to generate a quantitative understanding of the future challenge. Through this research, product attributes critical to inspection such as viscosity, presentation, and protein aggregation, are identified for each commercial and pipeline drug product. These attributes are paired with production forecasts to generate attribute focused inspection requirements through 2020, which are then mapped against current capabilities. Gaps identified between requirements and current infrastructure capabilities are determined and the scale quantified. These capability gaps are then segmented by potential solutions, complexity of solutions, and cost of inaction in order to give Amgen the best foresight into future decisions and investments. Based on the gaps identified and near term engineering challenges, several solutions are developed, proposed, and tested throughout the internship. These include the use of Surface Acoustic Waves (SAW) to agitate heavy particles into suspension through acoustic streaming, enhanced lighting and imaging techniques to better identify particles, and segmented machine vision algorithms. These approaches are part of a larger portfolio of technical solutions which must be developed to address future product attributes which render current inspection processes ineffective. Thesis Supervisor: Roy Welsch Title: Eastman Kodak Leaders for Global Operations Professor of Management, Engineering Systems Division Thesis Supervisor: Douglas Hart Title: Professor, Mechanical Engineering
منابع مشابه
Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s)
Background: This article sets up the initial discussion of the evolution of biopharmaceutical innovation in China through the perspective of sectoral innovation system (SIS).Methods: Two data sources including archival documentary data and field interviews were used in this study. Archival documentary data was collected from China Food and Drug Administration (CFDA) and Chinese National Knowled...
متن کاملWearable Computers: An Interface between Humans and Smart Infrastructure Systems
Monitoring and inspecting infrastructure systems are tasks as old as construction itself. Depending on the phase in their life cycle, these infrastructure systems have to be maintained, repaired, refurbished, or reconstructed. To ensure current and up-todate information about each piece of infrastructure, inspectors have to go and visit each part of the system to record the condition of each co...
متن کاملAssessment and Monitoring for Railway Tracks Reliability and Safety using Nondestructive Testing Measurement Systems
The deterioration of railway tracks raises great concerns about the integrity of assessments and evaluations of railway tracks currently in service. Integrated inspection strategies coupled with innovations in inspection technology can lead to significant improvements in operational cost efficiency and reliability without the requirement of a fundamental shift in the existing understanding o...
متن کاملBiopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s).
BACKGROUND This article sets up the initial discussion of the evolution of biopharmaceutical innovation in China through the perspective of sectoral innovation system (SIS). METHODS Two data sources including archival documentary data and field interviews were used in this study. Archival documentary data was collected from China Food and Drug Administration (CFDA) and Chinese National Knowle...
متن کاملPositioning SAS Software for Corporate Effectiveness
Accelerated research and development has increased industry reliance on Information Technology (IT). Biopharmaceutical IT divisions increasingly require an infrastructure capable of providing global enterprise-wide business solutions. However, when the application of IT innovation to business solutions occurs at an insufficient rate, business needs go unfulfilled. Of particular importance to ac...
متن کامل